Preventing apoptosis during the early stages of infection of a host cell is generally thought to result in a higher yield of progeny virus. The US3 protein kinase of pseudorabies virus (PRV) and herpes simplex virus (HSV) is able to protect infected cells from apoptosis, which may be one of the reasons why both US3null PRV and US3null HSV replicate to lower virus titres in several cell types. However, such potential correlation between the higher amount of apoptosis in US3null virus-infected cells and the lower virus titres of US3null virus has not been investigated directly. In the current study, we found that a broad-spectrum caspase-inhibitor efficiently inhibited apoptosis in swine testicle and human laryngeal epidermoid carcinoma cells infected with US3null or wildtype (WT) PRV. However, inhibition of apoptosis did not affect US3null or WT PRV extracellular or cell-associated virus titres, nor did it restore the small plaque phenotype of US3null PRV.
Apoptosis is a strictly regulated cellular process that plays an important role in a variety of biological processes (Thompson, 1995; Thomson, 2001) . Apoptosis of virusinfected cells early in the replication cycle is an intrinsic antiviral host defence mechanism (Koyama et al., 2000) .
Several viruses encode proteins with anti-apoptotic properties (Aubert & Blaho, 2001; Hay & Kannourakis, 2002; Thomson, 2001) . For Alphaherpesvirinae, the largest subfamily of the family Herpesviridae, the conserved US3 serine/threonine kinase has been shown to possess antiapoptotic properties in herpes simplex virus type 1 (HSV-1) (Benetti et al., 2003; Cartier et al., 2003a, b; Jerome et al., 1999; Leopardi et al., 1997; Munger et al., 2001; Munger & Roizman, 2001; Ogg et al., 2004) , HSV-2 (Asano et al., 1999 (Asano et al., , 2000 Hata et al., 1999; Murata et al., 2002) , varicellazoster virus (Schaap et al., 2005) , Marek's disease virus (Schumacher et al., 2008) and pseudorabies virus (PRV) (Deruelle et al., 2007; Geenen et al., 2005) , but not in bovine herpesvirus type 1 (Takashima et al., 1999) . Both PRV and HSV US3 render cells less susceptible to apoptosis induced by infection (Asano et al., 1999 (Asano et al., , 2000 Geenen et al., 2005; Leopardi et al., 1997) , overexpression of proapoptotic proteins of the Bcl-2 family (Ogg et al., 2004) , or several exogenous apoptotic stimuli (Cartier et al., 2003b; Geenen et al., 2005; Hata et al., 1999; Murata et al., 2002) .
The anti-apoptotic properties of PRV and HSV US3 may correlate with the fact that US3null PRV and US3null HSV reach lower end-point titres than the wild-type (WT) virus in different cell types (Kimman et al., 1994; ). Since such potential correlation between the higher amount of apoptosis in US3null virus-infected cells and the lower virus titres of a US3null virus has not been directly examined yet, we addressed this issue in the current study.
Two cell lines in which the anti-apoptotic properties of PRV US3 have been demonstrated before (Deruelle et al., 2007; Geenen et al., 2005; Ogg et al., 2004) were screened in order to verify whether US3null PRV titres were lower compared with those of WT PRV: swine testicle (ST) and human laryngeal epidermoid carcinoma (HEp-2) cells. Both cell lines were either WT or US3null PRV-infected at an m.o.i. of 10, and extracellular and cell-associated virus titres were determined at 24 h post-inoculation (p.i.) (Reed & Muench, 1938) . In ST cells, the extracellular US3null PRV titre was 1.1 logTCID 50 ml 21 lower than the WT PRV titre ( Fig. 1a ), which is similar to earlier observations (Van den Broeke et al., 2009a) . This difference was more pronounced in HEp-2 cells, where a 3.5 logTCID 50 ml 21 difference was observed ( Fig. 1a ). Cell-associated virus titres yielded similar results, albeit with somewhat smaller differences (0.73 and 2.6 logTCID 50 ml 21 for ST and HEp-2 cells, respectively) ( Fig. 1b ). Thus, US3null PRV replicates to lower virus titres than WT PRV in HEp-2 and, to a lesser extent, ST cells.
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On: Thu, 08 Aug 2019 07:56:11 ml 21 and 0.5 logTCID 50 ml 21 lower virus titres compared with WT PRV, respectively). This also fits with a previous report on HSV-1, stating that US3null HSV-1 showed impaired growth in HEp-2 cells (¢1 logTCID 50 ml 21 lower titres compared with WT HSV-1), but not in Vero cells .
To investigate the impact of apoptosis on PRV virus production and spread in ST and HEp-2 cells, a broadspectrum caspase inhibitor was first tested for its ability to prevent apoptosis in these cells upon PRV infection, and subsequently analysed for its ability to affect PRV virus production and/or spread.
First, the effect of the cell permeable and irreversible broadspectrum caspase inhibitor quinolyl-valyl-O-methylaspartyl-[2,6-difluorophenoxy]-methyl ketone (Q-VD-OPh; R&D Systems) on the level of PRV-induced apoptosis was examined. Q-VD-OPh has been shown to be more effective in preventing apoptosis than other pan-caspase inhibitors, and also to be equally effective in preventing apoptosis mediated by caspase 9/3, caspase 8/10 and caspase 12 involving pathways (Caserta et al., 2003) . Since the caspase inhibitor Q-VD-OPh was dissolved in DMSO, a solvent control to monitor any DMSO-related effect(s) was used. The percentage of apoptotic ST and HEp-2 cells upon mock, WT PRV or US3null PRV inoculation (m.o.i. 10), either in the absence or the presence of 10 mM Q-VD-OPh, was quantified at 24 h p.i. by immunofluorescence staining of active caspase-3 ( Fig. 2 ). Both in ST ( Fig. 2a ) and HEp-2 ( Fig. 2b ) cells, US3null PRV infection in the absence of Q-VD-OPh resulted in a fourfold higher percentage of apoptotic cells compared with WT PRV, confirming the anti-apoptotic properties of PRV US3 (Deruelle et al., 2007; Geenen et al., 2005; Van den Broeke et al., 2009a) . In contrast, almost no active caspase-3positive cells were detected upon WT or US3null PRV infection of ST and HEp-2 cells in the presence of 10 mM Q-VD-OPh. Hence, the broad-spectrum caspase inhibitor Q-VD-OPh efficiently blocks US3null PRV-induced apoptosis in both ST and HEp-2 cells, making it a suitable tool to study the effect of apoptosis on PRV virus production and spread.
Second, the effect of the inhibitor on WT and US3null PRV titres was tested in both ST and HEp-2 cells. Therefore, cells were inoculated with WT or US3null PRV (m.o.i. 10), in the absence or presence of 10 mM Q-VD-OPh, and both extracellular ( Fig. 3a ) and cell-associated ( Fig. 3b ) virus titres were determined at 24 h p.i. Addition of the broadspectrum caspase inhibitor Q-VD-OPh did not affect virus titres obtained for WT and US3null PRV in either cell type ( Fig. 3a, b) . These data indicate that the lower virus titres observed in US3null PRV-infected ST and HEp-2 cells are not due to the higher percentage of cells in late stages of apoptosis upon infection with US3null PRV.
Third, since US3null PRV displays a small plaque phenotype (Demmin et al., 2001) (Fig. 3c ), we checked whether inhibiting apoptosis increased the plaque size of US3null PRV or, as a control, WT PRV. ST cells were infected with US3null or WT PRV at a very low m.o.i. in either the presence or absence of 10 mM Q-VD-OPh. A final concentration of 1 % high viscosity sodium carboxymethylcellulose was used in order to disable secondary plaque formation. At 24, 48 and 72 h p.i., plaques were visualized by immunofluorescence staining of PRV antigens, and plaque sizes were measured by using the imageprocessing software ImageJ (Abramoff et al., 2004) . The efficacy of the inhibitor to inhibit apoptosis was checked at Fig. 1 . US3null PRV replicates to lower titres than WT PRV in HEp-2 and, to a lesser extent, ST cells. ST and HEp-2 cells were either WT PRV-or US3null PRV-infected at an m.o.i. of 10, and both extracellular (a) and cell-associated (b) virus titres were determined at 24 h p.i. Data represent the mean and standard deviation of three independent replicates. Differences between WT and US3null PRV titres indicated with an asterisk are statistically significant as calculated by the Student's t-test (P50.05). each time point (data not shown). Plaque sizes of US3null PRV were considerably smaller than WT PRV plaques at all time points tested, but the size of either US3null or WT PRV plaques was not affected by blocking caspasemediated apoptosis (Fig. 3c ). Since plaque assays were done over a period of 72 h p.i. and thus include several replication cycles, subtle differences in replication would be expected to accumulate over time and result in noticeable effects at 72 h p.i. Hence, the plaque assays further indicate that factors other than an increased percentage of cells in late stages of apoptosis are involved in the observed lower US3null PRV titres and viral spread. Further in line with this notion is our observation that ST cells have a modest defect in US3null PRV replication but are highly prone to apoptosis after US3null PRV infection, whereas the opposite is true for HEp-2 cells (Figs 1 and 2) .
It is highly unlikely that differences in virus titres and plaque sizes between WT and US3null PRV upon Q-VD-OPh treatment are due to caspase-independent apoptosis. Indeed, we demonstrated previously that quantification of apoptotic cells by staining of activated caspase-3 (caspasedependent apoptosis) or TUNEL assay (total apoptosis) gave similar results (Geenen et al., 2005) , indicating that the majority of, if not all, PRV-induced apoptosis is caspase-3-dependent. Q-VD-OPh was active at the different time points included in the study, which is in line with a previous report demonstrating that Q-VD-OPh is stable for at least 48 h (Caserta et al., 2003) , thereby excluding the possibility that the unaffected virus titres and plaque sizes were due to chemical breakdown of the inhibitor. To explain the lack of correlation between higher apoptosis levels, and lower virus titres and spread observed for US3null PRV, it may be of importance that we have reported before that apoptosis in US3null PRV-infected cells occurs late in infection, i.e. between 12 and 24 h p.i. (Geenen et al., 2005; Van den Broeke et al., 2009a) . Since alphaherpesviruses have a short replication time, leading to infectious virus production from as early as 6 h p.i. onwards, the bulk of infectious virus may be produced before apoptosis of US3null PRV-infected cells.
Interestingly, besides its role in anti-apoptosis, PRV US3 is also involved in the efficient de-envelopment of primary enveloped virus particles during viral egress from the nucleus (Klupp et al., 2001; Wagenaar et al., 1995) , and in the induction of actin cytoskeletal rearrangements . Based on our current data, it would appear relatively straightforward to correlate the defect in nuclear egress of a US3null virus with the reduced virus titres. However, there is evidence both pro and contra this hypothesis. Indeed, for HSV-1, it has been shown that a US3null virus displays an accumulation of primary enveloped virus particles in the perinuclear region of different cell types, including HEp-2 and Vero cells (Reynolds et al., 2002; . In contrast to HEp-2 cells, US3null HSV-1 has been found to replicate to WT levels in Vero cells , suggesting that the lower titres of a US3null virus may not be solely due to effects of US3 on nuclear egress. The effects of US3 on the actin cytoskeleton have recently been attributed to an interaction of US3 with p21-activated kinases (PAKs) 1 and 2, and extracellular PRV virus titres were reduced in PAK2 2/2 cells (Van den Broeke et al., 2009b) . Interestingly, PAKs are not only involved in rearrangements of the actin cytoskeleton, but also in anti-apoptotic effects (Cotteret et al., 2003; Gnesutta et al., 2001; Jakobi et al., 2001; Rudel & Bokoch, 1997; Schurmann et al., 2000; Tang et al., 2000) . Based on our current study, we hypothesize that the reduced PRV titres on PAK2 2/2 cells are probably due to the effect of PAK2 on the actin cytoskeleton, rather than the effect of PAK2 on apoptosis.
Although our data indicate that the lower virus titres observed for US3null virus are not directly correlated with the anti-apoptotic activity of US3, it is important to point out that we do not conclude that there is no correlation between viral anti-apoptotic strategies and a higher yield of infectious virus in general. As mentioned before, apoptosis in US3null PRV-infected cells occurs late in infection, when virus titres have already reached their maximum. This is possibly due to additional antiapoptotic viral proteins other than US3, at least partly compensating for the loss of US3 due to redundancy. In this case, a significantly reduced virus yield due to apoptosis should only be expected when several genes encoding anti-apoptotic proteins would be deleted. To date, for PRV, the US3 protein is the only viral protein that has been reported to possess anti-apoptotic properties. In contrast, several HSV-1-and HSV-2encoded anti-apoptotic proteins have been reported.
For HSV-1, it has been demonstrated that besides US3 Galvan & Roizman, 1998; Jerome et al., 1999; Leopardi et al., 1997) , US5 (gJ) (Aubert et al., 2008; Jerome et al., 1999 Jerome et al., , 2001 Zhou et al., 2000) , US6 (gD) , ICP4 (Galvan & Roizman, 1998; Leopardi & Roizman, 1996) , ICP22 and ICP27 proteins render cells less susceptible to different apoptotic stimuli. For HSV-2, besides US3 (Asano et al., 1999 (Asano et al., , 2000 Hata et al., 1999; Murata et al., 2002) , ICP10 (Golembewski et al., 2007; Perkins et al., 2002a Perkins et al., , b, 2003 has been reported to protect cells from apoptosis. It will be interesting to dissect the potential anti-apoptotic function of different PRV proteins and to determine their combined effect on infectious virus production. Taken together, in the current study, we confirm that PRV US3 has anti-apoptotic properties and that US3null PRV shows a reduction in the yield of infectious virus and virus spread efficiency. In addition, we found that the broadspectrum caspase inhibitor Q-VD-OPh, although efficiently inhibiting apoptosis in US3null PRV-infected cells, did not affect virus titres in US3null PRV-infected ST or HEp-2 cells, nor did it restore the small plaque phenotype of US3null PRV. Hence, based on our current data, it may be suggested that the effects of US3 on nuclear egress, the actin cytoskeleton, and/or still undefined processes, rather than on the apoptosis machinery, are involved in US3-mediated efficient infectious virus production and spread.
